BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20187580)

  • 21. Review. Pro- and anti-angiogenesis effects of resveratrol.
    Chen Y; Tseng SH
    In Vivo; 2007; 21(2):365-70. PubMed ID: 17436589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vinflunine: a new vision that may translate into antiangiogenic and antimetastatic activity.
    Aparicio LM; Pulido EG; Gallego GA
    Anticancer Drugs; 2012 Jan; 23(1):1-11. PubMed ID: 22027536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
    Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
    Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New anticancer agents: in vitro and in vivo evaluation of the antitumor and antimetastatic actions of various compounds isolated from medicinal plants.
    Kimura Y
    In Vivo; 2005; 19(1):37-60. PubMed ID: 15796155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-proliferation and anti-angiogenesis of curcumin-K30 solid dispersion.
    Chen C; Huang X; Cai H; Xu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Oct; 35(10):1029-36. PubMed ID: 21051827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiangiogenic phytochemicals and medicinal herbs.
    Jeong SJ; Koh W; Lee EO; Lee HJ; Lee HJ; Bae H; Lü J; Kim SH
    Phytother Res; 2011 Jan; 25(1):1-10. PubMed ID: 20564543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic cancer chemoprevention by phytochemicals.
    Boreddy SR; Srivastava SK
    Cancer Lett; 2013 Jun; 334(1):86-94. PubMed ID: 23111102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis.
    Hahm ER; Gho YS; Park S; Park C; Kim KW; Yang CH
    Biochem Biophys Res Commun; 2004 Aug; 321(2):337-44. PubMed ID: 15358181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiogenesis as a potential target of pharmaconutrients in cancer therapy.
    Granci V; Dupertuis YM; Pichard C
    Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):417-22. PubMed ID: 20453647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiogenesis: from plants to blood vessels.
    Fan TP; Yeh JC; Leung KW; Yue PY; Wong RN
    Trends Pharmacol Sci; 2006 Jun; 27(6):297-309. PubMed ID: 16697473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcuma as a functional food in the control of cancer and inflammation.
    Schaffer M; Schaffer PM; Zidan J; Bar Sela G
    Curr Opin Clin Nutr Metab Care; 2011 Nov; 14(6):588-97. PubMed ID: 21986478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of c-Jun induced by quercetin and resverol inhibits the expression and function of the androgen receptor in human prostate cancer cells.
    Yuan H; Pan Y; Young CY
    Cancer Lett; 2004 Sep; 213(2):155-63. PubMed ID: 15327830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiproliferative effects of resveratrol and the mediating role of resveratrol targeting protein NQO2 in androgen receptor-positive, hormone-non-responsive CWR22Rv1 cells.
    Hsieh TC
    Anticancer Res; 2009 Aug; 29(8):3011-7. PubMed ID: 19661309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of proliferative retinopathy by the anti-vascular agent combretastatin-A4.
    Griggs J; Skepper JN; Smith GA; Brindle KM; Metcalfe JC; Hesketh R
    Am J Pathol; 2002 Mar; 160(3):1097-103. PubMed ID: 11891206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiogenesis and antiangiogenic therapy in hematologic malignancies.
    Dong X; Han ZC; Yang R
    Crit Rev Oncol Hematol; 2007 May; 62(2):105-18. PubMed ID: 17188504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins.
    Kunnumakkara AB; Anand P; Aggarwal BB
    Cancer Lett; 2008 Oct; 269(2):199-225. PubMed ID: 18479807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability.
    Tozer GM; Prise VE; Wilson J; Cemazar M; Shan S; Dewhirst MW; Barber PR; Vojnovic B; Chaplin DJ
    Cancer Res; 2001 Sep; 61(17):6413-22. PubMed ID: 11522635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation combined with antiangiogenic and antivascular agents.
    O'Reilly MS
    Semin Radiat Oncol; 2006 Jan; 16(1):45-50. PubMed ID: 16378906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors.
    Sweeney CJ; Miller KD; Sissons SE; Nozaki S; Heilman DK; Shen J; Sledge GW
    Cancer Res; 2001 Apr; 61(8):3369-72. PubMed ID: 11309294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of aromatic enones related to curcumin.
    Robinson TP; Hubbard RB; Ehlers TJ; Arbiser JL; Goldsmith DJ; Bowen JP
    Bioorg Med Chem; 2005 Jun; 13(12):4007-13. PubMed ID: 15911313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.